Physician profile
Lisa Cox
NPI 1366824039
$3,769.11
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,591 · 2020: $1,005 · 2021: $1,104 · 2022: $68.60.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $640.34 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $542.37 | 2019-2022 | |
| Lilly USA, LLC | $509.77 | 2019-2021 | |
| Novo Nordisk INC | $400.23 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $385.36 | 2019-2021 | |
| Allergan, INC. | $306.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $282.67 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.95 | 2019-2020 | |
| Amgen INC. | $158.89 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $81.52 | 2019-2021 | |
| Glaxosmithkline, LLC. | $77.61 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $64.77 | 2020-2022 | |
| Abbvie INC. | $38.18 | 2021 | |
| Radius Health, INC. | $32.18 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $25.10 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.93 | 2021 | |
| Amarin Pharma, INC. | $13.28 | 2020 | |
| Merck Sharp & Dohme LLC | $12.61 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.44 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.